The Effect of Cholesterol in MCF7 Human Breast Cancer Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Mar 2023
Historique:
received: 01 03 2023
revised: 14 03 2023
accepted: 18 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

In the last decade, cholesterol level has been implicated in several types of cancer, including breast cancer. In the current study, we aimed to investigate the condition of lipid depletion, hypocholesterolemia or hypercholesterolemia reproduced in vitro to analyze the response of different human breast cancer cells. Thus, MCF7 as the luminal A model, MB453 as the HER2 model and MB231 as the triple-negative model were used. No effect on cell growth and viability was detected in MB453 and MB231 cells. In MCF7 cells, hypocholesterolemia (1) reduced cell growth, and Ki67 expression; (2) increased ER/PgR expression; (3) stimulated the 3-Hydroxy-3-Methylglutaryl-CoA reductase and neutral sphingomyelinase and; (4) stimulated the expression of CDKN1A gene coding cyclin-dependent kinase inhibitor 1A protein, GADD45A coding growth arrest and DNA-damage-inducible alpha protein and, PTEN gene coding phosphatase and tensin homolog. All these effects were exacerbated by the lipid-depleted condition and reversed by the hypercholesterolemic condition. The relationship between cholesterol level and sphingomyelin metabolism was demonstrated. In summary, our data suggest that cholesterol levels should be controlled in luminal A breast cancer.

Identifiants

pubmed: 36983016
pii: ijms24065935
doi: 10.3390/ijms24065935
pmc: PMC10052157
pii:
doi:

Substances chimiques

Cholesterol 97C5T2UQ7J
Lipids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Mol Sci. 2018 Nov 01;19(11):
pubmed: 30388783
Horm Cancer. 2016 Aug;7(4):219-28
pubmed: 27020054
Mol Ther Oncolytics. 2021 Oct 20;23:311-329
pubmed: 34786475
PLoS One. 2021 Oct 12;16(10):e0258363
pubmed: 34637456
Lancet. 2005 May 14-20;365(9472):1727-41
pubmed: 15894099
Oncol Lett. 2022 Dec 20;25(2):53
pubmed: 36644143
Int J Mol Sci. 2020 May 06;21(9):
pubmed: 32384654
Updates Surg. 2017 Sep;69(3):313-317
pubmed: 28260181
Agric Biol Chem. 1990 Nov;54(11):2961-6
pubmed: 1368650
J Hepatol. 2002 Mar;36(3):395-400
pubmed: 11867184
Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):879-88
pubmed: 17166408
Per Med. 2019 Jan;16(1):51-65
pubmed: 30468409
Biomed Pharmacother. 2021 Dec;144:112277
pubmed: 34624674
J Lipid Res. 1973 May;14(3):364-6
pubmed: 14580182
Arch Biochem Biophys. 2007 Mar 1;459(1):27-32
pubmed: 17196928
Cell Metab. 2014 Mar 4;19(3):393-406
pubmed: 24606897
Int J Mol Sci. 2022 Sep 23;23(19):
pubmed: 36232480
Eur J Cancer. 2010 Jun;46(9):1735-43
pubmed: 20434328
Front Immunol. 2022 Dec 23;13:1096009
pubmed: 36618348
PLoS Med. 2010 May 25;7(5):e1000279
pubmed: 20520800
Int J Mol Sci. 2021 Jan 13;22(2):
pubmed: 33450869
J Photochem Photobiol B. 2002 Apr;66(3):171-8
pubmed: 11960726
Hippocampus. 2010 Jun;20(6):696-705
pubmed: 19603526
Int J Mol Sci. 2019 Jul 25;20(15):
pubmed: 31349547
Int J Mol Sci. 2022 Jan 26;23(3):
pubmed: 35163332
Trends Cancer. 2017 Nov;3(11):753-760
pubmed: 29120751
Breast Cancer Res. 2018 Nov 20;20(1):144
pubmed: 30458856
Mol Cancer Res. 2008 May;6(5):795-807
pubmed: 18505924
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Nov;1863(11):1413-1422
pubmed: 30591148
Trends Biochem Sci. 2011 Feb;36(2):97-107
pubmed: 20870412
Cell Metab. 2019 Jun 4;29(6):1376-1389.e4
pubmed: 30930171
Anticancer Res. 2015 Jun;35(6):3147-54
pubmed: 26026074
Biochimie. 2018 Mar;146:35-42
pubmed: 29158006
Gene. 2016 Jan 15;576(1 Pt 1):22-7
pubmed: 26432005
Int J Cancer. 2023 Jan 5;:
pubmed: 36602287
FASEB J. 2014 Mar;28(3):1317-30
pubmed: 24327606
Oncol Lett. 2012 Apr 1;3(4):927-929
pubmed: 22741020
Int J Prev Med. 2022 Nov 23;13:142
pubmed: 36618541
Fed Proc. 1984 Jan;43(1):126-30
pubmed: 6690332
Int J Mol Sci. 2022 Nov 08;23(22):
pubmed: 36430205
Int J Mol Sci. 2022 Jul 05;23(13):
pubmed: 35806470
Circulation. 1987 Sep;76(3):504-7
pubmed: 3621516
Biomedicines. 2022 Aug 06;10(8):
pubmed: 36009455
Oncol Lett. 2017 Dec;14(6):6533-6542
pubmed: 29163687
Biol Chem. 2015 Jan;396(1):1-11
pubmed: 25205720
Int J Immunopathol Pharmacol. 2006 Apr-Jun;19(2):331-7
pubmed: 16831300
Breast Cancer Res. 2011 Aug 12;13(4):215
pubmed: 21884641
Cell Mol Life Sci. 2022 Jul 12;79(8):417
pubmed: 35819726
Ann Agric Environ Med. 2017 Dec 23;24(4):549-553
pubmed: 29284222
Lipids Health Dis. 2016 Jan 12;15:4
pubmed: 26754536
Radiol Technol. 2017 Mar;88(4):401M-421M
pubmed: 28298516
Lancet Oncol. 2014 Sep;15(10):e461-8
pubmed: 25186049
Front Biosci (Landmark Ed). 2022 Aug 17;27(8):247
pubmed: 36042186
J Intern Med. 2017 Jun;281(6):534-553
pubmed: 28295777
Open Access Maced J Med Sci. 2018 Jun 06;6(6):961-967
pubmed: 29983785

Auteurs

Elisabetta Albi (E)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Martina Mandarano (M)

Division of Pathological Anatomy and Histology, Department of Experimental Medicine, School of Medicine and Surgery, University of Perugia, 06126 Perugia, Italy.

Samuela Cataldi (S)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Maria Rachele Ceccarini (MR)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Federico Fiorani (F)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Tommaso Beccari (T)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Angelo Sidoni (A)

Division of Pathological Anatomy and Histology, Department of Experimental Medicine, School of Medicine and Surgery, University of Perugia, 06126 Perugia, Italy.

Michela Codini (M)

Department of Pharmaceutical Sciences, University of Perugia, 06126 Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH